Company: ARMP
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001558370-25-007765
Chunk: 17

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part II, Item 4
Chunk 17
---
 Current Report on Form 8-K, filed with the SEC on December 11, 2019).​​​3.7​Articles of Amendment to Articles of Incorporation of the Company (effective March 26, 2020) (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on March 30, 2020).​​​3.8​Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.5 to the Company’s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2019).​​​3.9​Amendment to Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed with the SEC on December 11, 2019).​​​3.10​Amendment to Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on February 26, 2020). ​​​4.1​Reference is made to Exhibits 3.1 through 3.10.​​​10.1​Credit and Security Agreement, dated March 12, 2025, by and among the Company and Innoviva Strategic Opportunities, LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on March 12, 2025).